Leading scientists, philanthropists, and policymakers from around the world are coming together at the Global Science Summit, hosted by the Novo Nordisk Foundation as part of our 100-year anniversary. The goal is to explore the interaction between the world’s biggest health and…

In a moment of serendipity, two then unknown chemists conversing in a pub laid the groundwork for a genomics revolution, dramatically reducing sequencing time and costs. The innovation of Professor Sir David Klenerman and Sir Shankar Balasubramanian not only paves the way for…

Much like humans, microorganisms are not inherently sustainable. However, like humans, they have the capability to become sustainable. When pressed, they can acquire this capability, thus proving to be an invaluable resource in humanity’s effort to create a balanced world.…

Today marked a special occasion, as we celebrated three worldclass researchers whose work has helped to pave the way for a sustainable and healthier future.
We are thrilled to award the Novo Nordisk Prize 2024 to Professors Sir David Klenerman and Sir Shankar Balasubramanian for…

On Tuesday, 11 June 2024, the Novo Nordisk Foundation will host a symposium to facilitate research partnerships and sow the seeds for realizing creative solutions and new technologies within the 2025 Challenge Programme theme: Ectopic fat and cardiometabolic disease.

Join us to…

The Novo Nordisk Foundation is excited to announce the four themes of its Challenge Programme 2025. The Programme addresses some of the major challenges facing society and the planet at large. It has a total budget of DKK 480 million (€64.3 million) and is now open for…

In 2023, we awarded more than DKK 9.1 billion in philanthropic grants and investments, supporting 751 new projects and initiatives. See our Grant Report 2023 - Benefitting people, society and the planet for more facts and figures, and to read about some of our major activities…

The Novo Nordisk Foundation proudly announces Professor Jack Pronk as the recipient of the 2024 Novozymes Prize for his groundbreaking contributions to industrial biotechnology. His transformative research in yeast physiology and metabolic engineering has not only revolutionised…

Denmark will soon have a national centre for innovation that will house one of the world’s most powerful AI supercomputers. But what is a supercomputer, and why would we want one? Watch the video to find out, and read more here: novonordiskfonden.dk/en/news/denmar…

#AI #supercomputer

Today, we launched the Danish Centre for AI Innovation at an event attended by His Majesty the King, Minister of Industry, Business and Financial Affairs Morten Bødskov, Minister for Interior and Health Sophia Løhde, and Minister for Higher Education and Science Christina…

AI is a technology with phenomenal capacity to benefit people and the planet. Here, Mads Krogsgaard Thomsen, CEO of the Novo Nordisk Foundation, and Lene Oddershede, Senior Vice President, talk about the new Danish Centre for AI Innovation.

The centre is being established in…

Denmark’s researchers and innovators will soon have access to vast supercomputing power, state-of-the-art software, and world-leading expertise to help realise the potential of AI technology across industries from healthcare and life science to the green transition.

The Novo…

Fremover vil hovedparten af Novo Nordisk Fondens forventede vækst i uddelinger ske uden for Danmark.

Det fortæller Lars Rebien Sørensen i et interview.

Novo Nordisk Foundation @novonordisk #dkbiz #dkøko

berlingske.dk/business/rebie…

Professors Sir David Klenerman and Sir Shankar Balasubramanian are being honoured with the 2024 Novo Nordisk Prize for their pioneering work, which enables the human genome to be sequenced in just an hour. This has opened the door to personalised healthcare and enhances our…

Infectious disease and vaccine expert Nicholas Jackson will lead the newly established Novo Nordisk Foundation Initiative for Vaccines and Immunity (NIVI) as Executive Director and CEO from 1 May. NIVI is a partnership with Københavns Uni.

Press release:…

Professor Antje Körner will receive the 2024 Obesity Prize for Excellence for groundbreaking research into the origin and consequences of childhood obesity.

The prize is awarded by EASO and the Novo Nordisk Foundation. Four other researchers will also receive the New…

Tilbage i 1980erne opdagede prof Jens Juul Holst tarmhormonet GLP-1, der i dag er hovedingrediens i bla slankemidlet Wegovy og diabetespræparatet Ozempic.
🎙️Hør #MånedensForsker Jens Juul Holst om opdagelsen og bliv klogere på hans aktuelle #dkforsk bit.ly/holst_podcast

Last week, the Novo Nordisk Foundation announced the extension and expansion of the Open Discovery Innovation Network (ODIN). This patent-free platform, now encompassing five Danish universities, significantly lowers the hurdles for collaboration between industry and academia.…

This International Women's Day, the Novo Nordisk Foundation celebrates the women who are leading the way in health and science. From bioengineering breakthroughs to innovative healthcare solutions, our grantees Professors Irina Borodina, Anja Boisen, and Mette Rosenkilde,…